𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Guidelines for the therapeutic use of botulinum toxin in movement disorders

✍ Scribed by C. A. Pagni; G. Abbruzzese; A. Berardelli

Publisher
Springer Milan
Year
1998
Tongue
English
Weight
94 KB
Volume
19
Category
Article
ISSN
1590-1874

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Botulinum toxin in the treatment of ling
Botulinum toxin in the treatment of lingual movement disorders
✍ Neema Kasravi; Mandar S. Jog πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 66 KB

## Abstract Lingual movement disorders are a rare but serious manifestation of neurologic disease, which have the potential to cause significant morbidity. Traditionally, these disorders were treated with pharmacotherapy achieving only limited results. Several case series have demonstrated the effe

Perioperative use of botulinum toxin for
Perioperative use of botulinum toxin for movement disorder–induced cervical spine disease
✍ Dr. Charles H. Adler; Richard S. Zimmerman; Mark K. Lyons; Fred Simeone; Mitchel πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 284 KB

Patients with cervical dystonia or tics of the nuchal muscles can develop serious cervical spine disease. We report a series of four patients who received botulinum toxin injections to control their movement disorders prior to their required surgery. One patient with cervical tic-induced radiculomye

Historical notes on botulism, Clostridiu
Historical notes on botulism, Clostridium botulinum, botulinum toxin, and the idea of the therapeutic use of the toxin
✍ Frank J. Erbguth πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 115 KB

Food-borne botulism probably has accompanied mankind since its beginning. However, we have only few historical sources and documents on food poisoning before the 19th century. Some ancient dietary laws and taboos may reflect some knowledge about the life-threatening consumption of poisoned food. One

Five-year experience in the treatment of
Five-year experience in the treatment of focal movement disorders with low-dose dysportTM botulinum toxin
✍ P. Van Den Bergh; J. Francart; S. Mourin; P. Kollmann; E. C. Laterre πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 987 KB

We report the results of botulinum toxin type A (Dysport"", Porton Products, UK) treatment over 5 years in 107 patients with blepharospasm, Meige's syndrome, oromandibular dystonia, hemifacial spasm, cervical dystonia, and writer's cramp. Electromyography was used to localize dystonic muscles and gu